標題: Titlebook: Cognitive Enhancement; Kathleen M. Kantak,Joseph G. Wettstein Book 2015 Springer International Publishing Switzerland 2015 Alzheimer‘s Dis [打印本頁] 作者: fathom 時間: 2025-3-21 18:39
書目名稱Cognitive Enhancement影響因子(影響力)
書目名稱Cognitive Enhancement影響因子(影響力)學科排名
書目名稱Cognitive Enhancement網絡公開度
書目名稱Cognitive Enhancement網絡公開度學科排名
書目名稱Cognitive Enhancement被引頻次
書目名稱Cognitive Enhancement被引頻次學科排名
書目名稱Cognitive Enhancement年度引用
書目名稱Cognitive Enhancement年度引用學科排名
書目名稱Cognitive Enhancement讀者反饋
書目名稱Cognitive Enhancement讀者反饋學科排名
作者: BAIT 時間: 2025-3-21 23:55
Hwa-Young Kim,Vadim N. Gladyshevt others. Impairments in cognition are prevalent in many neuropsychiatric and neurological disorders with few viable treatment options. The development of new therapies is challenging, and poor efficacy in clinical development continues to be one of the most consistent reasons compounds fail to adva作者: CLASH 時間: 2025-3-22 01:27
Hwa-Young Kim,Vadim N. Gladysheved in humans and rodents in the absence of pathological conditions, some individuals maintain intact cognitive functions up to an advanced age. The mechanisms underlying learning and memory processes involve the recruitment of multiple signaling pathways and gene expression, leading to adaptative ne作者: GULLY 時間: 2025-3-22 04:43
Selenoproteins and selenoproteomesm cells/precursors. Although the precise role of this process remains elusive, adult hippocampal neurogenesis is important for learning and memory and it is affected in disease conditions associated with cognitive impairment, depression, and anxiety. Immature neurons in the adult brain exhibit an en作者: Fallibility 時間: 2025-3-22 10:39
Selenium Assessment in Aquatic Ecosystemsectual function. Attention is inextricably linked to perception, learning and memory, and executive function; however, it is often impaired in a variety of neuropsychiatric disorders, including Alzheimer’s disease, schizophrenia, depression, and attention deficit hyperactivity disorder (ADHD). Accor作者: indubitable 時間: 2025-3-22 16:14 作者: indubitable 時間: 2025-3-22 19:16 作者: 禁令 時間: 2025-3-23 01:06
Emerging Selenium Contamination Issuese domain has been shown to provide a major determinant of outcome in schizophrenia and mood disorders. Therefore, verbal memory disturbances should be focused in the development of novel pharmacological and psychosocial therapeutics. Effective integration between preclinical and clinical studies sho作者: Compassionate 時間: 2025-3-23 03:54
Selenium Pollution Around the World:722–726, 2000) in a well-defined behavioral protocol (auditory fear conditioning in the rat). Since this study, reconsolidation has been demonstrated in hundreds of studies over a range of species, tasks, and amnesic agents. Evidence for reconsolidation does not come solely from the behavioral leve作者: Ankylo- 時間: 2025-3-23 07:40 作者: etidronate 時間: 2025-3-23 13:20 作者: DAUNT 時間: 2025-3-23 16:39 作者: Painstaking 時間: 2025-3-23 21:51 作者: 革新 時間: 2025-3-23 22:39
https://doi.org/10.1007/978-3-031-07063-1c or neurodegenerative illnesses, but also of healthy individuals. However, a number of lifestyle interventions are proven cognitive enhancers, improving attention, problem solving, reasoning, learning and memory or even mood. Several of these interventions, such as physical exercise, cognitive, men作者: Contend 時間: 2025-3-24 04:31
Jason L. Dutton,Paul J. Ragogna or emotion that we experience. Over the past decade, a novel neurotechnique, optogenetics that combines light and genetic methods to control or monitor neural activity patterns, has proven to be revolutionary in understanding the functional role of specific neural circuits. We here briefly describe作者: absorbed 時間: 2025-3-24 08:50 作者: Processes 時間: 2025-3-24 14:18
Kathleen M. Kantak,Joseph G. WettsteinEmphasizes individual cognitive domains, cutting across disease and disorder, with a perspective on the pharmacology for each.Maximizes insights into evolving themes that will bring cognitive research作者: expansive 時間: 2025-3-24 18:31 作者: heartburn 時間: 2025-3-24 22:11
Book 2015This book highlights the behavioral and neurobiological issues relevant for drug development, reviews evidence for an innovative approach for drug discovery and presents perspectives on multiple special topics ranging from therapeutic drug use in children, emerging technologies and non-pharmacological approaches to cognitive enhancement.作者: relieve 時間: 2025-3-25 01:46
https://doi.org/10.1007/978-3-319-16522-6Alzheimer‘s Disease; Neuroenhancement; attention deficit hyperactivity disorder; autism; bipolar disorde作者: fibroblast 時間: 2025-3-25 04:41 作者: artifice 時間: 2025-3-25 07:37
Cognitive Enhancement978-3-319-16522-6Series ISSN 0171-2004 Series E-ISSN 1865-0325 作者: multiply 時間: 2025-3-25 11:55 作者: 草率女 時間: 2025-3-25 16:59 作者: EXCEL 時間: 2025-3-25 23:06
Selenoproteins and selenoproteomesion, recent genetic approaches have shown that promoting neurogenesis can positively modulate cognition associated with both physiology and disease. Thus the discovery of signaling pathways that enhance adult neurogenesis may lead to therapeutic strategies for improving memory loss due to aging or d作者: Malaise 時間: 2025-3-26 04:07
Selenium Assessment in Aquatic Ecosystemsts for disorders of attention. These paradigms include two tasks of sustained attention that were developed as rodent analogues of the human Continuous Performance Task (CPT), the Five-Choice Serial Reaction Time Task (5-CSRTT) and the more recently introduced Five-Choice Continuous Performance Task作者: Colonoscopy 時間: 2025-3-26 04:40 作者: Vulvodynia 時間: 2025-3-26 12:15
Hydrological Units and Selenium Criteriary, more so in elderly than in young subjects. Studies investigating effects of registered anti-Alzheimer drugs, cholinesterase inhibitors in mild cognitive impairment, show positive and negative effects on declarative memory. Studies mainly carried out in healthy volunteers investigating the effect作者: 確定的事 時間: 2025-3-26 14:54 作者: Reservation 時間: 2025-3-26 18:16 作者: Constituent 時間: 2025-3-26 22:00
Animal Paradigms to Assess Cognition with Translation to Humansd incorporating non-rodent species (e.g., non-human primates) that may enable a closer comparison to humans, an improvement in the translatability of the results will be possible. This chapter focuses on some promising translational cognitive paradigms for use in rodents, non-human primates, and hum作者: 煞費苦心 時間: 2025-3-27 01:28
Signaling Pathways Relevant to Cognition-Enhancing Drug Targetss receptors, downstream signaling effectors [e.g., calcium/calmodulin-dependent protein kinase II (CaMKII), protein kinase C (PKC), extracellular signal-regulated kinases (ERK), mammalian target of rapamycin (mTOR), cAMP response element-binding protein (CREB)], associated immediate early gene (e.g.作者: 延期 時間: 2025-3-27 07:43
Role of Adult Hippocampal Neurogenesis in Cognition in Physiology and Disease: Pharmacological Targeion, recent genetic approaches have shown that promoting neurogenesis can positively modulate cognition associated with both physiology and disease. Thus the discovery of signaling pathways that enhance adult neurogenesis may lead to therapeutic strategies for improving memory loss due to aging or d作者: 裂縫 時間: 2025-3-27 13:03
Attentionts for disorders of attention. These paradigms include two tasks of sustained attention that were developed as rodent analogues of the human Continuous Performance Task (CPT), the Five-Choice Serial Reaction Time Task (5-CSRTT) and the more recently introduced Five-Choice Continuous Performance Task作者: 廣大 時間: 2025-3-27 16:45 作者: 搜尋 時間: 2025-3-27 18:15 作者: Offset 時間: 2025-3-27 22:35 作者: Ige326 時間: 2025-3-28 02:14 作者: uveitis 時間: 2025-3-28 07:34
Methods for Delivering and Evaluating the Efficacy of Cognitive Enhancementcan be facilitated through either pharmacological or remediation strategies. The critical goals of cognitive enhancement are to improve everyday functioning in multiple domains. This chapter describes the strategies that are most desirable for the treatment of cognitive impairments and detection of 作者: Sad570 時間: 2025-3-28 14:04
Animal Paradigms to Assess Cognition with Translation to Humanst others. Impairments in cognition are prevalent in many neuropsychiatric and neurological disorders with few viable treatment options. The development of new therapies is challenging, and poor efficacy in clinical development continues to be one of the most consistent reasons compounds fail to adva作者: gnarled 時間: 2025-3-28 14:37 作者: 神圣將軍 時間: 2025-3-28 20:05 作者: Anticoagulants 時間: 2025-3-29 01:48
Attentionectual function. Attention is inextricably linked to perception, learning and memory, and executive function; however, it is often impaired in a variety of neuropsychiatric disorders, including Alzheimer’s disease, schizophrenia, depression, and attention deficit hyperactivity disorder (ADHD). Accor作者: definition 時間: 2025-3-29 05:22
Executive Functionrsal learning), can be reliably modelled in rodents. The rodent paradigms are based upon tasks that assess cognitive flexibility in clinical populations and have been effective in distinguishing the neurobiological substrates and the underlying neurotransmitter systems relevant to executive function作者: Cholesterol 時間: 2025-3-29 09:11 作者: Defiance 時間: 2025-3-29 15:25
Verbal Memorye domain has been shown to provide a major determinant of outcome in schizophrenia and mood disorders. Therefore, verbal memory disturbances should be focused in the development of novel pharmacological and psychosocial therapeutics. Effective integration between preclinical and clinical studies sho作者: 陰謀 時間: 2025-3-29 15:51
Emotional Memory:722–726, 2000) in a well-defined behavioral protocol (auditory fear conditioning in the rat). Since this study, reconsolidation has been demonstrated in hundreds of studies over a range of species, tasks, and amnesic agents. Evidence for reconsolidation does not come solely from the behavioral leve作者: chemical-peel 時間: 2025-3-29 21:17 作者: Incumbent 時間: 2025-3-30 02:46
Neural Targets in the Study and Treatment of Social Cognition in Autism Spectrum Disordergy and neuroanatomical circuitry of ASD are first briefly described. The neuropharmacology of social cognition in animal models of ASD and humans is then addressed. Next, preclinical and clinical research on the neurohormone oxytocin is reviewed. This is followed by a presentation of results from pr作者: SSRIS 時間: 2025-3-30 06:08 作者: 不能約 時間: 2025-3-30 08:53
Pharmacological Disruption of Maladaptive Memoryl treatment. For example, posttraumatic stress disorder (PTSD) involves such strong reemergence of memories associated with a traumatic event that the individual feels like the event is happening again. Furthermore, drug addiction is characterized by compulsive use and repeated relapse that is often作者: 評論者 時間: 2025-3-30 12:31
Non-pharmacological Approaches to Cognitive Enhancementc or neurodegenerative illnesses, but also of healthy individuals. However, a number of lifestyle interventions are proven cognitive enhancers, improving attention, problem solving, reasoning, learning and memory or even mood. Several of these interventions, such as physical exercise, cognitive, men作者: 終端 時間: 2025-3-30 17:13 作者: vasospasm 時間: 2025-3-30 23:47 作者: Leisureliness 時間: 2025-3-31 02:14 作者: LASH 時間: 2025-3-31 06:25 作者: Cosmopolitan 時間: 2025-3-31 13:16 作者: elucidate 時間: 2025-3-31 17:13
Verbal Memory focused in the development of novel pharmacological and psychosocial therapeutics. Effective integration between preclinical and clinical studies should provide a key to the pursuit of drugs enhancing verbal memory.作者: 裝飾 時間: 2025-3-31 21:08
Optogenetics and Deep Brain Stimulation Neurotechnologiesor neural activity patterns, has proven to be revolutionary in understanding the functional role of specific neural circuits. We here briefly describe recent advance in optogenetics and compare optogenetics with deep brain stimulation technology that holds the promise for treating many neurological and psychiatric disorders.作者: 機構 時間: 2025-3-31 22:31 作者: 鍍金 時間: 2025-4-1 05:50 作者: obtuse 時間: 2025-4-1 09:39
0171-2004 nt, reviews evidence for an innovative approach for drug discovery and presents perspectives on multiple special topics ranging from therapeutic drug use in children, emerging technologies and non-pharmacological approaches to cognitive enhancement.978-3-319-35195-7978-3-319-16522-6Series ISSN 0171-2004 Series E-ISSN 1865-0325
